Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom

Published:2020-10-28 Issue:2 Volume:30 Page:237-247
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Arana Alejandro¹^ORCID,Margulis Andrea V¹,Varas‐Lorenzo Cristina¹,Bui Christine L²^ORCID,Gilsenan Alicia²^ORCID,McQuay Lisa J²,Reynolds Maria³,Rebordosa Cristina¹,Franks Billy⁴,Vogel Stefan⁴,Appenteng Kwame⁵,Perez‐Gutthann Susana¹^ORCID

Affiliation:

1. Pharmacoepidemiology and Risk Management RTI Health Solutions Barcelona Spain

2. Pharmacoepidemiology and Risk Management RTI Health Solutions Research Triangle Park North Carolina USA

3. Biostatistics RTI Health Solutions Research Triangle Park North Carolina USA

4. Astellas Leiden Netherlands

5. Astellas Northbrook Illinois USA

Funder

Astellas Pharma Global Development

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5150

Reference16 articles.

1. Data Resource Profile: Clinical Practice Research Datalink (CPRD)

2. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study

3. Validity of Cardiovascular Disease Event Ascertainment Using Linkage to UK Hospital Records

4. Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications

5. Primary care patient records in the United Kingdom: past, present, and future research priorities;McMillan B;J Med Internet Res,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study program;Pharmacoepidemiology and Drug Safety;2024-04-29

2. Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study;BMJ;2024-04-25

3. Validity of Routine Health Data To Identify Safety Outcomes of Interest For Covid-19 Vaccines and Therapeutics in the Context of the Emerging Pandemic: A Comprehensive Literature Review;Drug, Healthcare and Patient Safety;2024-01

4. Incidence and individual risk prediction of post-COVID-19 cardiovascular disease in the general population: a multivariable prediction model development and validation study;European Heart Journal Open;2023-09-28

5. Guideline concordance for timely chest imaging after new presentations of dyspnoea or haemoptysis in primary care: a retrospective cohort study;Thorax;2023-08-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3